⌘K

Login Start Free

Home/Filings/4/0000912282-25-001407

4//SEC Filing

Thye Dirk 4

Accession 0000912282-25-001407

CIK 0001662774other

View on SEC.gov Company Profile

Filed

Dec 11, 7:00 PM ET

Accepted

Dec 12, 5:07 PM ET

Size

6.0 KB

Accession

0000912282-25-001407

Insider Transaction Report

Form 4

Period: 2025-12-10

Quince Therapeutics, Inc.QNCX

DirectorCEO and CMO

Transactions

Gift
Common Shares
2025-12-10−739,885→ 255,000 total

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

Quince Therapeutics, Inc.

CIK 0001662774

Entity typeother

Related Parties

1

filerCIK 0001638945

Filing Metadata

Form type: 4
Filed: Dec 11, 7:00 PM ET
Accepted: Dec 12, 5:07 PM ET
Size: 6.0 KB

View on SEC.gov